CONFIRM anti-Thymidine Phosphorylase (P-GF.44C) Mouse Monoclonal Primary Antibody - SFDA Registration ME0000001000SFDAA00187
Access comprehensive regulatory information for CONFIRM anti-Thymidine Phosphorylase (P-GF.44C) Mouse Monoclonal Primary Antibody in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000001000SFDAA00187 and manufactured by Ventana Medical Systems, Inc..
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Reagent to recognizes human thymidine phosphorylase
Ventana Medical Systems’ (Ventana) CONFIRM anti- Thymidine Phosphorylase (PGF. 44C) Mouse Monoclonal Primary Antibody recognizes human thymidine phosphorylase, an angiogenic factor, expressed in varying levels by macrophages, stromal cells, glial cells and some epithelial cells. Thymidine phosphorylase shows a cytoplasmic and/or nuclear location. This antibody exhibits a nuclear and/or cytoplasmic staining pattern and may be used to aid in the detection of thymidine phosphorylase in carcinoma of the breast, esophagus, stomach, colon and rectum, pancreas, head and neck, ovaries and lung. The antibody is intended for qualitative staining in sections of formalin fixed, paraffin embedded tissue. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls.
[]